Treatment of Recurrent Dupuytren Disease

被引:9
|
作者
Kaplan, Frederick Thomas D. [1 ]
Crosby, Nicholas E. [1 ]
机构
[1] Indiana Hand Shoulder Ctr, 8501 Harcourt Rd, Indianapolis, IN 46260 USA
关键词
Dupuytren disease; Recurrence; Outcomes; Collagenase Clostridium histolyticum; Aponeurotomy; Dermofasciectomy; Continuous passive elongation; COLLAGENASE CLOSTRIDIUM-HISTOLYTICUM; PROXIMAL INTERPHALANGEAL JOINT; CONTRACTURE; FASCIECTOMY; SURGERY; DERMOFASCIECTOMY; COMPLICATIONS; MANAGEMENT;
D O I
10.1016/j.hcl.2018.03.009
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Treatment of recurrent Dupuytren disease is challenging. Multiple options exist, each having relative benefits and weaknesses. Choice for optimal treatment is made on a case-by-case basis, with shared decision-making with the patient. Percutaneous and enzymatic techniques are best reserved for patients with welldefined recurrent disease and offer the benefit of quicker recovery with minimal or no scarring. Surgical treatments have higher risks of neurovascular injury and scarring but lower recurrence rates. Staged continuous passive elongation followed by dermofasciectomy may lower neurovascular injury and improve outcomes. Salvage procedures may be necessary in patients with poor tissue beds and neurovascular compromise.
引用
收藏
页码:403 / +
页数:14
相关论文
共 50 条
  • [41] Impact of Collagenase Injection on Dupuytren Disease Treatment in Japan
    Yoneda, Hidemasa
    Curley, James
    Yamamoto, Michiro
    Hirata, Hitoshi
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 44 - 50
  • [42] DUPUYTREN DISEASE
    NARAKAS, A
    BEDESCHI, P
    GENERAL SURGERY : CURRENT STATUS AND FUTURE TRENDS, 1989, 60 : 283 - 285
  • [43] Enzyme injection as nonsurgical treatment of Dupuytren's disease
    Badalamente, MA
    Hurst, LC
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2000, 25A (04): : 629 - 636
  • [44] Molecular mechanisms and treatment strategies for Dupuytren's disease
    O'Gorman, David B.
    Vi, Linda
    Gan, Bing Siang
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 383 - 390
  • [45] Treatment of Dupuytren's disease with collagenase Clostridium histolyticum
    Keller, M.
    Arora, R.
    Schmiedle, G.
    Kastenberger, T.
    ORTHOPADE, 2017, 46 (04): : 321 - 327
  • [46] 1ST RESULTS IN THE TREATMENT OF DUPUYTREN DISEASE
    BRAY, E
    GALEAZZI, M
    ARTHRITIS AND RHEUMATISM, 1980, 23 (12): : 1408 - 1408
  • [47] Surgical treatment of a case of congenital Dupuytren's disease
    Zheng, Huai Yuan
    Liu, Juan
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2013, 66 (03): : E76 - E78
  • [48] Collagenase Treatment for Dupuytren Disease of the Thumb and First Web
    Dreise, Marieke M.
    Stenekes, Martin W.
    Werker, Paul M. N.
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2016, 41 (03): : 348 - +
  • [49] Collagenase in the treatment of Dupuytren's disease: An in vitro study
    Starkweather, KD
    Lattuga, S
    Hurst, LC
    Badalamente, MA
    Guilak, F
    Sampson, SP
    Dowd, A
    Wisch, D
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1996, 21A (03): : 490 - 495
  • [50] Treatment Options for Dupuytren's Disease: Tips and Tricks
    Denkler, Keith A.
    Park, Keon Min
    Alser, Osaid
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2022, 10 (01) : E4046